Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Ketorolac in High Risk Breast Cancer
NCT01806259Phase 3Completed
- Sponsor
- UCLouvain
- Start
- Feb 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac in breast cancer, sponsored by UCLouvain. Started Feb 2013; status: completed.
02
Drugs
ketorolac
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01806259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806259.